Novo Nordisk's Fiasp (insulin aspart injection) Receives the FDA's Approval for use in Insulin Infusion Pumps to Treat Type 1 or Type 2 Diabetes | PharmaShots
Pertinent Data for Patients and Their Conventional Insulin Pump at Baseline | Download Table
Overnight versus 24 Hours of Continuous Subcutaneous Insulin Infusion as Supplement to Oral Antidiabetic Drugs in Type 2 Diabete
Insulin Pump Risks and Benefits: A Clinical Appraisal of Pump Safety Standards, Adverse Event Reporting, and Research Needs | Diabetes Care
Insulin 100 years
Insulin 100 years
Novo Nordisk to launch connected insulin pens - PMLiVE
FDA OKs Novo Nordisk's Fiasp for infusion pumps - MassDevice
Novo Nordisk's new insulin pens will integrate with Abbott's Freestyle Libre system | MobiHealthNews
Fully closed-loop insulin delivery improves glucose control of inpatients with type 2 diabetes receiving hemodialysis - Kidney International
Insulin Pump Therapy for Type 2 Diabetes | Medtronic Diabetes
Insulin Pump Therapy for Type 2 Diabetes | Medtronic Diabetes
Novo Nordisk launches new Rybelsus pill for type 2 diabetes in the UK | Pharmafile
Clinical Research News | Metabolic Research Institute | West Palm Beach
Insulin pumps in general practice - Australian Prescriber
Insulin Pump Therapy for Type 2 Diabetes | Medtronic Diabetes
Health Canada approves fast-acting mealtime insulin, Fiasp®, for children with diabetes
Insulin pumps in general practice - Australian Prescriber
EU Approves Novo Nordisk's Pre-filled Insulin Cartridge for the New Accu-Chek Insight Insulin Pump
Fiasp® Onset of Appearance | Fiasp® (insulin aspart injection) 100 U/mL
FDA approves Fiasp in insulin infusion pumps for adults — Juicebox Podcast and Arden's Day
Diabetes Devices Market: Increase in Adoption of Insulin Pump among Type 1 Diabetes Patients Boost Market Growth | Medgadget
Novo Nordisk and Roche' insulin pump system gets EU thumbs up
Insulin pump treatment compared with multiple daily injections for treatment of type 2 diabetes (OpT2mise): a randomised open-label controlled trial - The Lancet
The Latest and Greatest in Insulin Pumps and Sensor Technology - Taking Control Of Your Diabetes
